GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 147 filers reported holding GERON CORP in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,954 | -51.7% | 20,733 | -26.9% | 0.00% | – |
| Q2 2023 | $91,068 | +99.3% | 28,370 | +34.8% | 0.00% | – |
| Q1 2023 | $45,683 | +552.6% | 21,052 | +345.2% | 0.00% | – |
| Q2 2022 | $7,000 | +75.0% | 4,729 | +81.9% | 0.00% | – |
| Q1 2022 | $4,000 | +33.3% | 2,600 | -0.9% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 2,623 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -50.0% | 2,623 | -53.6% | 0.00% | – |
| Q2 2021 | $8,000 | -70.4% | 5,653 | -66.8% | 0.00% | – |
| Q1 2021 | $27,000 | +800.0% | 17,023 | +741.5% | 0.00% | – |
| Q4 2020 | $3,000 | -25.0% | 2,023 | +1.2% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 2,000 | -1.1% | 0.00% | – |
| Q2 2020 | $4,000 | – | 2,023 | +8695.7% | 0.00% | – |
| Q3 2019 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 23 | -99.6% | 0.00% | -100.0% |
| Q2 2018 | $21,000 | +5.0% | 6,000 | +20.0% | 0.00% | 0.0% |
| Q1 2018 | $20,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 5,732,770 | $7,854,000 | 1.22% |
| RA Capital Management | 30,126,299 | $41,273,000 | 0.57% |
| NEA Management Company, LLC | 13,461,538 | $18,442,000 | 0.22% |
| Virtus ETF Advisers LLC | 146,618 | $201,000 | 0.09% |
| Forefront Analytics, LLC | 82,336 | $113,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 226,098 | $310,000 | 0.03% |
| Summit X, LLC | 84,077 | $114,000 | 0.03% |
| Poehling Capital Management, INC. | 53,000 | $73,000 | 0.02% |
| Arnhold LLC | 154,700 | $212,000 | 0.02% |
| Vishria Bird Financial Group, LLC | 20,615 | $28,000 | 0.02% |